Navigation Links
TeraRecon Appoints Jeff Sorenson as Senior Vice President Sales and Marketing
Date:8/6/2013

FOSTER CITY, Calif., Aug. 6, 2013 /PRNewswire/ -- TeraRecon, (www.terarecon.com), a leading provider of enterprise medical image management solutions, today announced the appointment of Jeff Sorenson as Senior Vice President responsible for global sales, marketing and business development

(Photo: http://photos.prnewswire.com/prnh/20130806/SF59438)

From 2004 until 2011, Mr. Sorenson served in several key executive roles within TeraRecon and was instrumental in setting the vision, specifications and sales strategy for the award-winning iNtuition product line. Most recently, he served as Director of Healthcare Sales and Solutions for a leading provider of enterprise clinical content management solutions.  Prior to this, Jeff served as Director of Marketing at GE-Imatron and held various customer service roles at Philips Healthcare.

TeraRecon is positioning itself for rapid growth within new adjacent markets and ensuring that its install base of enterprise iNtuition customers can leverage their TeraRecon investments more widely in new clinical care areas and workflow scenarios.

"We are delighted to have Jeff rejoin our management team to drive our company's growth strategy," said recently appointed interim chief executive officer Lakshmi Lakshminarayan. He continued, "As the chief financial officer working closely with Jeff for many years, I have seen the company's revenues and innovative spirit flourish under his leadership.  He brings a highly-effective combination of sales strategy, operational acumen and healthcare IT expertise."

Jeff Sorenson, Senior Vice President said, "The opportunity in front of us at TeraRecon is to be at the forefront of innovation once again by combining our core competencies in image post-processing and
'/>"/>

SOURCE TeraRecon
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Astellas Appoints New Senior Vice President of Global Oncology Development
2. Advanced Prenatal Therapeutics Appoints Dr. Nihar Nayak to its Scientific Advisory Board
3. Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
4. Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
5. PDL BioPharma Appoints David Montez as Controller and Chief Accounting Officer
6. Exalenz Bioscience Appoints Gavin Doree New VP of Sales to Lead Companys New Direct Sales Organization in the U.S.
7. Hologic Appoints Jack W. Cumming President and Chief Executive Officer
8. Cellular Biomedicine Group Appoints Director of Medical Research
9. PDL BioPharma Appoints Glenn Reicin as Senior Advisor
10. PAREXEL International Appoints Ingo Bank As Senior Vice President And Chief Financial Officer
11. Dynatronics Appoints R. Scott Ward, PT PhD to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ... it has completed the acquisition of leading OTC brands ... €200 million. The transaction is a clear demonstration of ... Company,s leading European distribution network spanning 36 countries.  ... C. Papa commented, "We are excited to complete ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015  Mylan ... its shareholders have approved Mylan,s proposed acquisition of ... and the related issuance of Mylan ordinary shares ... of shareholders held today. The transaction received the ... general meeting. In addition, the transaction received support ...
(Date:8/28/2015)... India , August 28, 2015 ... Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ... , Asia-Pacific , and Rest of the ... MarketsandMarkets, The global market for Eubiotics was valued at USD ... 7.05 Billion by 2020, at a CAGR of 7.4% from ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... 2011 PharmAthene, Inc. (NYSE Amex: PIP ... a U.S. Phase I clinical trial of its fully ... prevention and treatment of inhalational anthrax. The ... to evaluate single escalating doses of 1, 5, or ...
... April 13, 2011 Two new studies published in ... Related Diseases, a peer-reviewed journal, add to the ... LAP-BAND® Adjustable Gastric Banding System, made by Allergan, Inc. ... effective weight-loss procedure. One study concluded that laparoscopic adjustable ...
Cached Medicine Technology:PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial 2PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial 3New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 2New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 3New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 4New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 5New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 6New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 7New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 8New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions 9
(Date:8/29/2015)... , ... August 29, 2015 , ... ... angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are at higher risk ... angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia or irregular heartbeat) ...
(Date:8/28/2015)... ... ... Rio Salado College joined nine educational institutions in Washington D.C., ... EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded by the ... Incubator hosted by EDUCAUSE and NGLC, which is designed to bring leadership teams ...
(Date:8/28/2015)... New Port Richey, FL (PRWEB) , ... August 28, 2015 , ... ... that while many potential workers are qualified for the position they are applying for, ... work. Because of this, many employers are considering altering drug testing policies in order ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Understanding the FDA’s Position and Best Practices for Compliance, **Presented by FDAnews ... This workshop, chaired by internationally renowned expert Fubin Wu, has been specifically ...
(Date:8/28/2015)... ... August 28, 2015 , ... Loved ones of a ... struggling with chemical dependency, may be able to find some hope in the ... treatment center for addiction located in Western Michigan. Focusing on several different aspects ...
Breaking Medicine News(10 mins):Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... News) -- Progressive scar damage to transplanted kidneys may be ... says a new study. The research included 797 patients ... followed for at least five years. One year after ... signs of progressive scar damage on their new kidney. After ...
... researchers have developed an educational booklet that can help patients ... out of every 16 Americans will be diagnosed with colon ... Most patients survive colon cancer if the cancer ... that can identify and remove polyps from the entire colon. ...
... Maryland, April 12, 2011 Neuralstem, Inc. (NYSE Amex: ... of the Phase I safety trial of Neuralstem,s human ... (ALS or Lou Gehrig,s disease), and unpaid Neuralstem consultant, ... Dr. Feldman reported yesterday at the American Academy of ...
... PARIS, Texas April 12, 2011 Recruitment for ... in the U.S. is now under way in Lamar ... Center, along the Texas-Oklahoma border. The multicenter study ... age 21 to determine how various factors, including environmental ...
... sentinel node (SN) procedure in breast cancer is based on ... tissue drains is clean, the remaining lymph nodes in the ... This was developed to limit surgical overtreatment and reduce morbidities ... in the initial years of the SN procedure, surgeries actually ...
... multiple sclerosis (MS) worry how quickly the disease will ... in a commonly performed diagnostic test, Mayo Clinic researchers ... of disability and counsel them to help ease anxiety. ... of Neurology meeting in Honolulu, Hawaii. Progressive MS ...
Cached Medicine News:Health News:New educational booklet helps patients prepare for a colonoscopy 2Health News:New educational booklet helps patients prepare for a colonoscopy 3Health News:PI presents safety results in Neuralstem ALS Stem Cell Trial 2Health News:PI presents safety results in Neuralstem ALS Stem Cell Trial 3Health News:UT Southwestern pediatricians launch landmark children's health study 2Health News:UT Southwestern pediatricians launch landmark children's health study 3Health News:Mayo Clinic finds tool to predict disability timeline for progressive MS patients 2
... plate system is a family of plates ... provides for consistent, reliable fixation of plate ... or backout. This innovative design eliminates the ... implant your screws and the swivel ring ...
Relocatable frame has been designed specifically for fractionated stereotactic radiotherapy treatments. It provides a fast, non-invasive and reproducible fixation of the patient....
... of one part only, is made of a ... Polyamide may be rotated and moved as desired, ... and shapes, as well. Moreover they secure a ... caudal direction, which is one of the inalienable ...
VG1 ALIF (Anterior) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Medicine Products: